These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Value and limitations of two dimensional echocardiography in assessment of cardiomyopathy. DeMaria AN; Bommer W; Lee G; Mason DT Am J Cardiol; 1980 Dec; 46(7):1224-31. PubMed ID: 6450529 [TBL] [Abstract][Full Text] [Related]
28. Usefulness and limitations of dobutamine-atropine stress echocardiography for the diagnosis of coronary artery disease in patients with left bundle branch block. A multicentre study. Geleijnse ML; Vigna C; Kasprzak JD; Rambaldi R; Salvatori MP; Elhendy A; Cornel JH; Fioretti PM; Roelandt JR Eur Heart J; 2000 Oct; 21(20):1666-73. PubMed ID: 11032693 [TBL] [Abstract][Full Text] [Related]
29. Relation between extent of cardiac muscle cell disorganization and left ventricular wall thickness in hypertrophic cardiomyopathy. Maron BJ; Wolfson JK; Roberts WC Am J Cardiol; 1992 Sep; 70(7):785-90. PubMed ID: 1519531 [TBL] [Abstract][Full Text] [Related]
31. The distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: comparison to athletes and hypertensives. Shapiro LM; Kleinebenne A; McKenna WJ Eur Heart J; 1985 Nov; 6(11):967-74. PubMed ID: 2934251 [TBL] [Abstract][Full Text] [Related]
32. Prevalence of dignostic abnormalities in patients with genetically transmitted asymmetric septal hypertrophy. ten Cate FJ; Hugenholtz PG; van Dorp WG; Roelandt J Am J Cardiol; 1979 Apr; 43(4):731-7. PubMed ID: 570800 [No Abstract] [Full Text] [Related]
33. Disproportionate intraventricular septal hypertrophy in Nigerians with essential hypertension. Ajayi AA; Akintomide AO; Babalola RO; Akinwusi O Afr J Med Med Sci; 1995 Mar; 24(1):93-6. PubMed ID: 7495208 [TBL] [Abstract][Full Text] [Related]
34. Tetralogy of Fallot, pulmonary valve stenosis, ventricular septal defect, and hypertrophic cardiomyopathy in WKY/NCrj rats. Kuribayashi T; Shimoo K; Nakamura T; Taniwaki H; Hamaoka K; Nakagawa M; Ibata Y; Komeda T; Nagaoka A Pediatr Res; 1990 May; 27(5):483-7. PubMed ID: 2140601 [TBL] [Abstract][Full Text] [Related]
35. Hypertrophic cardiomyopathy in the dog. Liu SK; Maron BJ; Tilley LP Am J Pathol; 1979 Mar; 94(3):497-508. PubMed ID: 154845 [TBL] [Abstract][Full Text] [Related]
36. [Hypertrophic cardiomyopathy with ventricular septal hypertrophy localized to the apical region of the left ventricle (apical ASH)]. Koga Y; Takahashi H; Ifuku M; Itaya M; Adachi K; Toshima H J Cardiogr; 1984 Aug; 14(2):301-10. PubMed ID: 6543446 [TBL] [Abstract][Full Text] [Related]
37. Canine hypertrophic cardiomyopathy. Liu SK; Maron BJ; Tilley LP J Am Vet Med Assoc; 1979 Apr; 174(7):708-13. PubMed ID: 429233 [TBL] [Abstract][Full Text] [Related]
38. [Evaluation of septal hypertrophy and wall dynamics by biventricular cineangiography and endomyocardial biopsy]. Genda A; Taga K; Nunoda S; Takeda R J Cardiogr Suppl; 1984; (3):101-10. PubMed ID: 6543588 [TBL] [Abstract][Full Text] [Related]
39. Familial hypertrophic cardiomyopathy: vectorcardiographic findings in echocardiographically unaffected relative. Loperfido F; Fiorilli R; Digaetano A; Di Gennaro M; Santarelli P; Bellocci F; Coppola E; Zecchi P Br Heart J; 1982 Jun; 47(6):588-95. PubMed ID: 7200794 [TBL] [Abstract][Full Text] [Related]
40. Regional left ventricular wall thickening. Relation to regional uptake of 18fluorodeoxyglucose and 201Tl in patients with chronic coronary artery disease and left ventricular dysfunction. Perrone-Filardi P; Bacharach SL; Dilsizian V; Maurea S; Frank JA; Bonow RO Circulation; 1992 Oct; 86(4):1125-37. PubMed ID: 1394920 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]